When should subcutaneous heparin be stopped as prophylaxis for deep vein thrombosis?

When to Stop Subcutaneous Heparin for DVT Prophylaxis

Subcutaneous heparin for DVT prophylaxis should be discontinued when the patient becomes fully ambulatory or at hospital discharge, whichever comes first, with duration typically ranging from 7-14 days for most hospitalized patients. 1

Duration by Clinical Context

Acutely Ill Medical Patients

• Stop prophylaxis at hospital discharge or when patient regains full mobility 1
• Guidelines recommend against extending thromboprophylaxis beyond the period of patient immobilization or acute hospital stay (Grade 2B) 1
• Continue throughout hospitalization for patients at increased thrombotic risk 2

Surgical Patients (Non-Orthopedic)

Standard duration: 7-10 days or until fully ambulatory 2

For patients at higher VTE risk, consider extending prophylaxis:

• Up to 28-35 days post-discharge for major abdominal/pelvic surgery 2
• Cancer patients undergoing major surgery should receive 4 weeks of LMWH 2

The most widely used regimen is 5,000 units subcutaneously every 8-12 hours, started 2 hours before surgery and continued for 7 days or until full ambulation 3, 4

Orthopedic Surgery Patients

Minimum 10-14 days, with strong consideration for extending to 35 days 2

• Total hip/knee replacement: 10-14 days minimum, consider up to 35 days (Grade 2B) 2
• Hip fracture surgery: Similar duration recommendations 2
• Extended prophylaxis (3-4 weeks) has demonstrated significant reduction in post-discharge DVT 5

Critical Care Patients

• Continue prophylaxis throughout ICU stay and acute illness period 1
• Transition to mechanical prophylaxis if bleeding risk becomes prohibitive 1

Key Decision Points for Discontinuation

Stop heparin prophylaxis when:

1. Patient achieves full ambulation - the primary endpoint for most medical and surgical patients 3, 4

2. Bleeding risk outweighs thrombotic risk - switch to mechanical prophylaxis (graduated compression stockings or intermittent pneumatic compression) 1

3. Transitioning to therapeutic anticoagulation - if DVT/PE develops despite prophylaxis, discontinue prophylactic dosing and initiate full therapeutic anticoagulation 3

4. Hospital discharge in standard-risk patients - for medical patients and most general surgery patients without additional risk factors 1

Important Caveats

Do not stop prematurely in high-risk populations:

• Cancer patients undergoing major surgery require extended prophylaxis (4 weeks minimum) 2
• Major orthopedic surgery patients benefit from 28-35 days of prophylaxis 2, 5
• Patients with previous VTE, active malignancy, or multiple risk factors may require extended duration 2

Avoid common pitfalls:

• Stopping at arbitrary time points without assessing mobility status
• Failing to extend prophylaxis in high-risk surgical patients (particularly orthopedic and cancer surgery)
• Discontinuing prophylaxis in medical patients who remain immobilized despite hospital discharge to rehabilitation facilities

The evidence strongly supports that the period of immobilization and acute illness defines the prophylaxis duration, not arbitrary calendar days, though practical minimum durations (7-14 days) and maximum durations (28-35 days for high-risk surgery) provide useful boundaries 1, 2.